Functional studies using CRISPR/Cas9 gene editing, siRNA-mediated silencing, and selective inhibitors such as SD70 have demonstrated that KDM4C suppression reduces tumor cell migration and metastasis in both in vitro and in vivo models [15]. Here, KDM4C is linked to neoplasm.